PTEN and cancer: The absence of mitochondrial oxidative phosphorylation in cancer cells may provide them with survival advantages; this results in an increase in NADH levels, which results the inactivation of PTEN through a redox modification mechanism and activation of the Atk survival pathway, which provides cancer cells with drug resistance and improved ability to survive during hypoxia (Pelicano et al., 2006).